Molecular targets in lymphomas.
A large proportion of patients with lymphomas are curable with standard chemotherapy. There is a plateau, however, in cure rate with chemotherapy alone. Advances in molecular biology have led to a better understanding of the pathogenesis of lymphomas. This article provides examples of how molecular therapy is going to change the treatment of lymphomas.